Tissue platinum concentration and tumor response in non-small-cell lung cancer - sprookjes - yvandenbroek - TriplyDB

Tissue platinum concentration and tumor response in non-small-cell lung cancer

Tissue platinum concentration and tumor response in non-small-cell lung cancer

http://www.wikidata.org/entity/Q36222930

about

C-Jun N-terminal kinase signalling pathway in response to cisplatin Role of copper transporters in platinum resistance Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.Percutaneous Fine-Needle 5% Ethanol-Cisplatin Intratumoral Injection Combined with Second-Line Chemotherapy Improves On the Standard of Care in Patients with Platinum-Pretreated Stage IV Non-Small Cell Lung Cancer Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patients miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin.Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy.Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment.A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG.Overcoming platinum drug resistance with copper-lowering agents.DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.Advances in personalized therapy for lung cancer.Advances in cervical cancer pharmacotherapies.Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing.Chemotherapy Resistance in Lung Cancer.A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer.Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.Organic cation transporter 6 directly confers resistance to anticancer platinum drugs.Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells.Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer.Intratumoral injection of cisplatin in various concentrations of ethanol for cisplatin-resistant lung tumors.Current chemotherapies for advanced hepatocellular carcinoma.Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer.miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis.

P2860

Q26745463-961687ED-8E0D-40D2-98AC-B41038615BF3 Q26767028-32E4B965-C209-4313-A0B7-BDB5E9B4BD0B Q26863490-F1D769FE-4D5A-4444-A00E-69EEC6B82232 Q28552143-1A71A1B9-1944-4CBF-9D08-A85D972DB753 Q28818313-72F43810-8B7C-42FE-AE7E-C205F6DE3CAA Q33798999-BAF92009-B29B-481C-BA54-1DA520E08D43 Q33875938-D0E682FC-2888-49F5-B0C2-0BDFCB1D59DD Q33912220-93C0BC90-62F2-4D3E-9E19-30112F0724AC Q35744111-E8EE3B18-49E8-4931-8059-2CE254CEBC17 Q35744147-838C991F-F602-420F-8010-B0D5A7DA4EDE Q36499755-552EC423-F24B-4558-90E8-6F7FCD3496C9 Q36817080-B8A2D096-F2FA-4252-A1E2-A7A2794FE913 Q36841450-4E5C42BA-B10E-42FD-B95A-8C0D61442277 Q37185747-E4D5DFBA-5B24-4A9A-ACC8-CB81B44ACE05 Q37500149-3FEE4F61-E036-484F-AEF8-9D5959DDF184 Q37727299-488BB18D-7807-4FBE-8321-C50C8338931F Q37736567-5033BF70-9F16-41A6-87D3-EE0C2151647B Q38127786-A1F35052-314A-47B0-AEB9-0E83DC33D235 Q38184593-9EED6147-EE20-436B-A4D2-B115B73954ED Q38186660-96EFD5E8-BBE6-4610-AE8E-409CEC286C5E Q38669287-F44EB566-1CA5-45F9-B270-63EEB521E621 Q38706298-42BB27B2-D5F8-4994-B776-DBFE36C5D1C2 Q38728212-9D3872EB-8EB7-46BA-8E56-B3F604D45649 Q38729178-D2CA3FBE-450E-4D0E-A37F-BCD73724E6C7 Q38796115-3235722F-4C78-4A35-AA45-E44D47F077F3 Q38899756-FF12A7CE-7398-4550-B8E1-35DF8C79103B Q40515209-5EAB99C3-4BE3-4F7B-A82D-A39CBD44AD2C Q40729549-F77D56C3-0C4A-40C8-B49C-5681762056DC Q41276800-675E73FE-EC3B-49C2-BEBC-95EFACA7F9A9 Q46018831-FBA92116-C97A-421A-ADDA-6623663F4C8E Q47733035-12FCE35D-1B5C-4817-B988-3AF7FD2F943F Q53811526-2B9C15B1-C45D-4A1A-B657-E75493214F5C Q55007009-7EEB3C35-3E4C-49F5-8B3D-EC99E1B6002D Q55091136-F0EC9F6D-1899-4B26-8BB4-9CE32D1959C4

P2860

Tissue platinum concentration and tumor response in non-small-cell lung cancer

http://www.wikidata.org/entity/Q36222930

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Tissue platinum concentration and tumor response in non-small-cell lung cancer

@ast

Tissue platinum concentration and tumor response in non-small-cell lung cancer

@en

type

label

Tissue platinum concentration and tumor response in non-small-cell lung cancer

@ast

Tissue platinum concentration and tumor response in non-small-cell lung cancer

@en

prefLabel

Tissue platinum concentration and tumor response in non-small-cell lung cancer

@ast

Tissue platinum concentration and tumor response in non-small-cell lung cancer

@en

P1433

Q36222930-DA6ED04B-11E6-4099-8086-169E333FD319

P1476

Q36222930-1F06B1C1-94D7-4CE4-B1E0-6C9C35CBEF54

P2093

Q36222930-29450290-F268-416B-8381-193274C7FE30

Q36222930-4A887296-1AA5-476E-95D1-1E90A8C125CE

Q36222930-4BDCC325-B3D0-42D3-AAD0-31473C6430F7

Q36222930-5759AD96-DD5E-4AEF-937A-55A982556D40

Q36222930-74EBBA74-91D5-46E4-B0A9-0304CE6D13AF

Q36222930-7AC175CC-57D5-4FB3-AA27-E44F46E40F6D

Q36222930-ADB4DB77-0A24-4356-900C-4B2815431578

Q36222930-B8AD1465-B973-4CF6-AAD8-0619A5E81626

Q36222930-FFEEE254-145A-49A1-8C89-E281FAA7CF67

P2860

Q36222930-0057CB73-731E-4836-A7A5-435829EA4A02

Q36222930-04A9D4CB-9858-42FB-B250-400A394607F7

Q36222930-05D4EECF-61F7-4AC9-ACEF-CC85A95C52A4

Q36222930-0C983907-FE84-44C4-91D7-6AECDAD7CA0D

Q36222930-0DCA50CF-3432-4C75-97DA-6228B3CC6FB2

Q36222930-1AD6FCF4-A963-43AA-85BF-9C4DF296B70F

Q36222930-1FD92416-9DE5-450F-A801-24BF450B2337

Q36222930-2E423DCE-66FA-4BB2-83A7-2C69FFDC61F2

Q36222930-2E98F927-024A-4B27-AAAE-1C10AB2B69E7

Q36222930-324820E0-DA56-444B-AD1D-D56DAB9951C8

P304

Q36222930-7C221D06-5607-4F89-855C-9923B0ACEF6D

P31

Q36222930-629560E2-9A1D-40B2-99DA-0CA4F5EDD93C

P356

Q36222930-433EA70F-D46A-4C67-BAF8-10803C082C88

P407

Q36222930-EE9D90CC-AC41-4446-9DFE-02714849ABEF

P433

Q36222930-CF948EC7-18F4-4C8C-B302-B6F080CD849E

P478

Q36222930-D55AC629-1BF6-4739-9AE6-4A280078AAA2

P50

Q36222930-94A87CA1-7B1D-4345-96F9-9AAC8566C855

P577

Q36222930-85B4917E-D8F8-4DF0-9B72-65A072103F1A

P698

Q36222930-4D59B623-A3FB-4C23-82BE-F37E9A1FEAD4

P932

Q36222930-5E72D559-2EBB-4856-BDBB-75D194A1E6D1

P356

JCO.2011.40.8120

P1433

Journal of Clinical Oncology

P1476

Tissue platinum concentration and tumor response in non-small-cell lung cancer

@en

P2093

Chi-Wan Chow

http://www.w3.org/2001/XMLSchema#string

David J Stewart

http://www.w3.org/2001/XMLSchema#string

Eric S Kim

http://www.w3.org/2001/XMLSchema#string

Guangan He

http://www.w3.org/2001/XMLSchema#string

J Jack Lee

http://www.w3.org/2001/XMLSchema#string

Junya Fujimoto

http://www.w3.org/2001/XMLSchema#string

Neda Kalhor

http://www.w3.org/2001/XMLSchema#string

Stephen G Swisher

http://www.w3.org/2001/XMLSchema#string

Zahid H Siddik

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer

Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance

Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.

Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy

Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.

Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy

P304

3345-3352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.40.8120

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Ignacio I Wistuba

P577

2012-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22891266

http://www.w3.org/2001/XMLSchema#string

P932

3438232

http://www.w3.org/2001/XMLSchema#string